Analyst Price Targets — PRPH
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 17, 2022 4:28 am | — | H.C. Wainwright | $140.00 | $76.00 | Benzinga | HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $14 |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for PRPH

ProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average – What’s Next?
ProPhase Labs, Inc. (NASDAQ: PRPH - Get Free Report) shares passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $1.24 and traded as low as $0.1035. ProPhase Labs shares last traded at $0.1198, with a volume of 56,021 shares trading hands. Wall Street Analyst Weigh In
Defense World • Apr 24, 2026
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PRPH.
U.S. House Trading
No House trades found for PRPH.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
